WEHI (Walter and Eliza Hall Institute of Medical Research)

🚀 Ready to launch your career in medical research? With world-class facilities, expert mentors and a collaborative research community, WEHI’s PhD program offers an environment where students can grow and thrive. Here, discoveries in cancer, immunity, infection, developmental disorders and ageing are transformed into life-changing solutions. Apply now to take your first step toward a global research career ➡

🔬 PhD scholarships for international students in Melbourne 🎓 WEHI’s PhD program gives international students more than scholarship support — you’ll have expert mentors, access to world-class facilities, and a collaborative research community where you can thrive. Your discoveries could advance knowledge in cancer, immune health, infection, developmental disorders and healthy ageing. Apply today to take the next step in your research career ➡

🌍 Looking for a PhD abroad? WEHI offers scholarships for exceptional students to pursue research in medical biology at one of Australia’s leading institutes. Our PhD program offers access to cutting-edge facilities, expert mentors, and a collaborative research community tackling some of the biggest challenges in health. International students are invited to apply and become part of our thriving biomedical precinct in Melbourne.

More than 30 medical research institutes. Uniting for one day. With one shared goal: to help fund the breakthroughs that improve and save lives. This is Australia’s first-ever National Medical Research Giving Day, and you are invited to be part of a historic collective effort. Choose WEHI to make a difference and help push research forward.

🎓 Considering Honours, Masters or PhD study in 2027? Come along to WEHI’s Student Open Day on Thursday 3 September and discover what postgraduate research could look like for you. Explore 45+ research projects across cancer, immune and infectious diseases, healthy development and ageing, computational biology, new medicines and advanced technologies. You’ll also have the chance to tour our labs and see biomedical research in action. 👩🔬👨🔬 Meet our researchers and current students 🔬 Discover our research projects available for 2027 📝 Learn about the application process and scholarships 🧬 Discover what a career in biomedical research could look like 📅 Thursday 3 September ⏰ 4–6pm 📍 WEHI – 1G Royal Parade, Parkville 🎟️ Register your attendance: https://lnkd.in/gmbtXGa4

🔬 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮 𝗱𝗼𝗲𝘀𝗻’𝘁 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗰𝗮𝘁𝗰𝗵 𝘂𝗽 𝗶𝗻 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 – 𝗶𝘁 𝗰𝗮𝗻 𝗹𝗲𝗮𝗽 𝗮𝗵𝗲𝗮𝗱. We run world‑class clinical trials, yet most treatments tested here are discovered overseas. While Australian scientists generate brilliant discoveries, too few are translated into medicines, companies and industries at home. But it’s in that gap that WEHI’s Professor Guillaume Lessene sees our greatest opportunity – a chance to design a future-ready biotech ecosystem from the ground up, rather than retrofitting the past. Right now, less than 5% of cancer drugs entering Australian clinical trials originate from local discovery pipelines. With the right capabilities, technologies and sustained, mission-scale investment, that figure could be far higher – delivering better medicines, high‑value jobs and stronger sovereign capability. Significant national investments like the National Drug Discovery Centre and MedChem Australia have already laid critical foundations – initiatives made possible through support from the Australian Government Department of Health, Disability and Ageing, via the Medical Research Future Fund. By deploying technologies such as AI, machine learning and spatial omics – and preparing now for future quantum capabilities – we can start to rethink drug discovery from first principles. For Prof Lessene, Associate Director of Therapeutic Discovery at WEHI, it’s a rare chance to leapfrog traditional biopharmaceutical models rather than follow the slow, incremental paths taken elsewhere. “Drug discovery today is a marathon that takes years and costs billions. “Combining a bold vision with AI, ML and future quantum computing tools, it could be a sprint – faster, smarter and delivering life-changing medicines and diagnostics sooner." The ultimate goal? Flip the equation – from dependency to resilience. From 5% to 50% locally-discovered clinical trial candidates. As debate turns toward bold, mission‑driven reform of Australia’s R&D system, and a 10-year vision for health and medical research, the opportunity is clear: ambitious national goals and sustained investment in translation could accelerate innovation, lift productivity and keep more value onshore. Read Professor Guillaume Lessene’s full perspective on why Australia’s biotech future can be designed – not retrofitted. 👉 https://lnkd.in/g3WNxq9r 📸 Professor Guillaume Lessene, WEHI’s Associate Director of Therapeutic Discovery, at the National Drug Discovery Centre. AusBiotech | Therapeutic Innovation Australia | MTPConnect | BioMelbourne Network | Department of Industry, Science and Resources | Melbourne Therapeutics (MTx) #Biotech #MedicalInnovation #ResearchTranslation #FutureMadeInAustralia #DrugDiscovery #AI #MRFF